Automated Insulin Delivery Wins FDA Clearance for Type 2 Diabetes

Sequel Med Tech won FDA clearance to extend its twiist automated insulin delivery system to adults with type 2 diabetes, a population the company estimates at 5.5 million insulin users in the US. The pharmacy-dispensed pump pairs with popular continuous glucose monitors and continuously adjusts basal insulin using the Tidepool Loop algorithm.